IL6 and blood coagulation disease: At the molecular level, there is a significant increase in pro-inflammatory cytokines and angiogenic growth factors, including vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6), which contribute to endothelial dysfunction and the progression of coagulopathy [4].